by Pharmaguapa | Oct 25, 2020 | Autoimmune Disease, hashimoto's, Leadership
This week was Thyroid awareness week. Admittedly I missed most of it because I wasn’t aware it was happening. So rather belatedly I wanted to share a bit of my own experience as a Hashimoto’s patient. It has taken me a while to get here but I can truly...
by Pharmaguapa | Oct 10, 2020 | Autoimmune Disease, hashimoto's, Patient centric, Social Media
Today is world mental health day. I have been quite open about my own battles with mental health, a result of my Hashimoto’s. In fact I received the diagnosis for depression six months before they identified that it was actually a symptom of thyroid disease. ...
by Pharmaguapa | Sep 20, 2020 | Autoimmune Disease, hashimoto's, Patient centric, Social Media
I was on a call last week where I found myself giving input into a brand strategy not as strategy consultant but as a patient advocate. My day job is advising life science’s companies on how to engage with their customers using digital technology. This...
by Pharmaguapa | Mar 29, 2020 | Autoimmune Disease, General, hashimoto's
We are currently going through some desperate times. In fact it is apparently so bad here that my cat Don has resorted to drinking from the toilet! Joking aside we are indeed going through some difficult times, especially if you are someone with a preexisting...
by Pharmaguapa | Mar 20, 2020 | Autoimmune Disease, Facebook, Social Media, Twitter
The WHO director general, Dr. Tedros Adhanom Ghebreyesus, made the point recently: “We’re not just fighting an epidemic; we’re fighting an infodemic”. It is a sad sign of our times that our health professionals and organisations not only have to deal...
by Pharmaguapa | Feb 2, 2020 | Autoimmune Disease, marketing, Multichannel, Strategy
Those of us living in the UK are going through a huge change as we negotiate Brexit and leave the EU. Like any massive, fundamental change this will require time and skillful planning and change management. After decades within a system, and a certain status quo, we...
